Tuesday, December 3, 2019

Eris Lifesciences acquires Zomelis trademark for Indian market from Novartis AG

The trademark has been used for marketing Vildagliptin formulations; an oral anti-diabetic drug that has been promoted in India for close to 10 years.

from India Infoline News Service https://ift.tt/2DH0yoC
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)